Following five days of treatment, hair grew in ten days

Researchers have revealed a new drug that caused mice to regrow hair in just three weeks.

It is hoped the discovery, which has also been shown to work on human hair follicles, could lead to a breakthrough in treatment of baldness.

It works by inhibiting a family of enzymes inside hair follicles that are suspended in a resting state, effectively 'waking' the hair.

Scroll down for video

The drugs work by inhibiting a family of enzymes inside hair follicles that are suspended in a resting state, effectively 'waking' the hair. Within 3 weeks, mice that received topical ruxolitinib or tofacitinib had regrown nearly all their hair (right photo; drug was applied only to the right side of the mouse). Little to no hair growth occurred in control mice during the same timeframe (left photo).

HOW IT WORKS Hair follicles do not produce hair steadily, but cycle between dormant and active phases. JAK inhibitors trigger the follicles' normal reawakening process, the researchers found. Mice treated for five days with one of two JAK inhibitors sprouted new hair within 10 days, greatly accelerating the onset of hair growth. No hair grew on control mice within the same amount of time. Advertisement

In experiments with mouse and human hair follicles, Angela Christiano of Columbia University Medical Center, found that drugs that inhibit the Janus kinase (JAK) family of enzymes promote rapid and robust hair growth when applied to the skin.

'What we've found is promising, though we haven't yet shown it's a cure for pattern baldness,' said Dr. Christiano.

'More work needs to be done to test if JAK inhibitors can induce hair growth in humans using formulations specially made for the scalp.'

The research, published today in the online edition of Science Advances, raises the possibility that JAK inhibitors could be used to restore hair growth in forms of hair loss induced by male pattern baldness, and other types of hair loss that occur when hair follicles are trapped in a resting state.

Two JAK inhibitors have been approved by the U.S. Food and Drug Administration.

One is approved for treatment of blood diseases (ruxolitinib) and the other for rheumatoid arthritis (tofacitinib).

Both are being tested in clinical trials for the treatment of plaque psoriasis and alopecia areata, an autoimmune disease that causes hair loss.

Christiano and her colleagues accidentally discovered the effect of JAK inhibitors have on hair follicles when they were studying alopecia areata, a form of hair loss that's caused by an autoimmune attack on the hair follicles.

Dr. Christiano noticed that mice grew more hair when a drug being tested was applied to the skin than when the drug was given systemically.

This suggested JAK inhibitors might be doing something to the hair follicles in addition to stopping the immune attack.

When the researchers looked more closely at normal mouse hair follicles, they found that JAK inhibitors rapidly awakened resting follicles out of dormancy.

Hair follicles do not produce hair steadily, but cycle between dormant and active phases.

JAK inhibitors trigger the follicles' normal reawakening process, the researchers found.

The study could lead to a new treatment for male pattern baldness, allowing sufferers to regrow hair in a matter of weeks. However, researchers say this is still some way off.

Mice treated for five days with one of two JAK inhibitors sprouted new hair within 10 days, greatly accelerating the onset of hair growth.

No hair grew on control mice within the same amount of time.

'There aren't many compounds that can push hair follicles into their growth cycle so quickly,' said Dr. Christiano.

'Some topical agents induce tufts of hair here and there after a few weeks, but very few compounds have this potent an effect so quickly.'

The drugs also produce longer hair from human hair follicles grown in culture and on skin grafted onto mice.

It's likely that the drugs act on the same pathways in human follicles as they do in mice, suggesting they could induce new hair growth and extend the growth of existing hairs in humans.